Psychedelics diverges from marijuana’s blueprint

Psychedelics diverges from marijuana’s blueprint

The nascent psychedelics industry is taking a different path to market than the marijuana sector, despite their shared medicinal roots.

While most states moved to regulate commercial medical marijuana programs without an extensive library of research, psychedelics advocates are adopting a different strategy.

Continue reading.

Photo by Farzan Lelinwalla on Unsplash

Source:

Share